Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 136 (2), 168-175
- https://doi.org/10.1016/s0022-3476(00)70097-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998
- A Review of Attenuation of Influenza Viruses by Genetic ManipulationAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Mucosal Vaccines for the Prevention of InfluenzaDrugs, 1995
- A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A DiseaseThe Journal of Infectious Diseases, 1994
- Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulenceMicrobial Pathogenesis, 1987
- Characterization of an influenza a host range mutantVirology, 1983
- Evaluation of a Cold-Recombinant Influenza Virus Vaccine in FerretsThe Journal of Infectious Diseases, 1982
- Cold-Adapted Recombinant Influenza A Virus Vaccines in Seronegative Young ChildrenThe Journal of Infectious Diseases, 1982
- Influenza in ChildrenPublished by American Medical Association (AMA) ,1980
- Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60Virology, 1979